889126-33-4 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 1-(2-chloropyrimidin-4-yl)piperidine-4-carboxylate is used as an intermediate compound for the synthesis of various pharmaceutical products. Its unique chemical structure allows it to be a key component in the development of new drugs, particularly in the treatment of diseases that require targeted therapies.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 1-(2-chloropyrimidin-4-yl)piperidine-4-carboxylate is used as a precursor in the production of pesticides and other agrochemicals. Its chemical properties make it a valuable component in the formulation of effective and targeted pest control solutions.
Used in Research and Development:
Methyl 1-(2-chloropyrimidin-4-yl)piperidine-4-carboxylate is also utilized in research and development settings, where it serves as a model compound for studying the properties and reactions of organohalogens. This helps in understanding the behavior of similar compounds and contributes to the advancement of chemical knowledge in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 889126-33-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,1,2 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 889126-33:
(8*8)+(7*8)+(6*9)+(5*1)+(4*2)+(3*6)+(2*3)+(1*3)=214
214 % 10 = 4
So 889126-33-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H14ClN3O2/c1-17-10(16)8-3-6-15(7-4-8)9-2-5-13-11(12)14-9/h2,5,8H,3-4,6-7H2,1H3
889126-33-4Relevant articles and documents
FUSED TRIAZOLE TACHYKININ RECEPTOR ANTAGONISTS
-
Page/Page column 29-30, (2008/06/13)
The present invention is directed to certain fused triazole compounds which are useful as neurokinin-1 (NK-I) receptor antagonists, and inhibitors of tachykinin and in particular substance P- The invention is also concerned with pharmaceutical formulation
CYCLOALKYL KETO PIPERIDINE TACHYKININ RECEPTOR ANTAGONISTS
-
Page/Page column 28, (2008/06/13)
The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations co
CYCLOALKYL PIPERIDINE TACHYKININ RECEPTOR ANTAGONISTS
-
Page/Page column 22-23, (2010/11/08)
The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations co
